Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, October 06, 2015
Osmotica Pharmaceutical has announced the appointment of Samer Kaba, M.D. as Vice President, Head of Global Clinical Development and Medical Affairs.
read more
Wednesday, March 18, 2020
OSE Immunotherapeutics and Servier announced the execution of an amendment to the two-step global licensing option agreement for exclusive global rights to interleukin-7 receptor antagonist OSE-127.
read more
Thursday, November 07, 2019
OSE Immunotherapeutics announced a new licensing deal with Chong Kun Dang (CKD) Pharmaceutical Corporation for Tedopi.
read more
OSE Immunotherapeutics and Cenexi, a French contract development and manufacturing organization (CDMO), announced the signature of an agreement whereby Cenexi will manufacture clinical batches of CoVepiT, OSE Immunotherapeutics' vaccine candidate ...
read more
Ortho Clinical Diagnostics announced an international distribution and co-promotion agreement with Thermo Fisher Scientific to provide 14 assays used to monitor therapeutic drugs, immunosuppressive drugs and drugs of abuse.
read more
Orion Contract Manufacturing has signed a commercial supply agreement with Peptonic Medical for the manufacture and packaging of its patented product, VagiVital.
read more
Wednesday, December 14, 2016
The Wisconsin Technology Innovation Initiative (Wi2), a non-profit organization formed to support the School of Medicine and Public Health at the University of Wisconsin-Madison, and Orion Corporation, a Finnish pharmaceutical and diagnostics ...
read more
Monday, November 03, 2025
Abzena announced that Orion has obtained an exclusive focused commercial license to one of Abzena’s monoclonal antibodies (mAbs) that targets a cancer of high clinical unmet need. The antibody will strengthen Orion’s broad oncology-focused drug ...
read more
Origenis has entered into a global license and collaboration agreement with Expansion Therapeutics to research and discover small molecule compounds targeting RNA-mediated diseases.
read more
ORIG3N, announced the launch of a unique partnership with Innovasalud to bring health and wellness DNA Tests to Latin America.
read more
Orientation Marketing, a pharmaceutical and life science marketing agency, opened a new office in Espoo, Finland to serve its growing client base in the Nordic and EU regions.
read more
Orgenesis it has entered into a Collaboration Agreement with Educell, a European cell therapy company.
read more
OrganaBio announced the opening of a new laboratory facility in Irvine, California, further expanding its reach and capabilities from the southeast to the west coast.
read more
Wednesday, August 21, 2019
Orexo has entered into an exclusive agreement with GAIA AG for a new digital therapy (DTx) for the treatment of Opioid Use Disorder (OUD). Orexo will have the exclusive global commercial rights to the product and intends to launch it in the US in ...
read more
Monday, November 13, 2017
Orexigen Therapeutics announced its wholly owned subsidiary and Merck KGaA, Darmstadt, Germany have executed a distributorship agreement for Contrave.
read more